Editorial
Published on 12 May 2022
Editorial: Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.900130
- 998 views
Type at least 3 characters
997 articles
Articles
Case Report
Published on 12 May 2022
Case Report: A Case Report of Neurosyphilis Mimicking Limbic Encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.862175
- 2,855 views
- 5 citations
Brief Research Report
Published on 11 May 2022
Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.889613
- 5,212 views
- 7 citations
Original Research
Published on 10 May 2022
Reproducibility of Lesion Count in Various Subregions on MRI Scans in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.843377
- 1,585 views
- 1 citation
Systematic Review
Published on 10 May 2022
Epileptic Seizures and Right-Sided Hippocampal Swelling as Presenting Symptoms of Anti-IgLON5 Disease: A Case Report and Systematic Review of the Literature
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.800298
- 1,901 views
- 3 citations
Original Research
Published on 09 May 2022
Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.836337
- 2,492 views
- 1 citation
Original Research
Published on 09 May 2022
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.863105
- 4,110 views
- 2 citations
Original Research
Published on 09 May 2022
Instrumented Assessment of Motor Performance Fatigability During the 6-Min Walk Test in Mildly Affected People With Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.802516
- 1,213 views
- 3 citations
Original Research
Published on 09 May 2022
Factors Influencing Social Participation Among Persons With Neuromyelitis Optica Spectrum Disorders: A Cross-Sectional Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.843909
- 1,211 views
- 2 citations
Original Research
Published on 06 May 2022
Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.891064
- 1,705 views
Review
Published on 29 Apr 2022
Cerebellar and/or Brainstem Lesions Indicate Poor Prognosis in Multiple Sclerosis: A Systematic Review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.874388
- 13,340 views
- 3 citations
Original Research
Published on 29 Apr 2022
Low Contrast Visual Evoked Potentials for Early Detection of Optic Neuritis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.804395
- 2,438 views
Case Report
Published on 29 Apr 2022
Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.872734
- 5,617 views
- 8 citations
Mini Review
Published on 28 Apr 2022
Fatigue in Multiple Sclerosis: A Review of the Exploratory and Therapeutic Potential of Non-Invasive Brain Stimulation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.813965
- 4,494 views
- 13 citations
Case Report
Published on 27 Apr 2022
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.897275
- 3,178 views
- 11 citations
Study Protocol
Published on 26 Apr 2022
Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)
in Multiple Sclerosis and Neuroimmunology
Frontiers in Neurology
doi 10.3389/fneur.2022.830057
- 1,743 views